Cerebrolysin in the treatment of brain injuries of moderate severity
Talypov, A.E.; Myachin, M.Y.; Kuksova, N.S.; Kordonsky, A.Y.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 98-106
2014
ISSN/ISBN: 1997-7298 PMID: 25591645 Document Number: 674973
To assess the efficacy of cerebrolysin in patients with cranial/brain injury of moderate severity. The main group included 30 patients treated with cerebrolysin from the first day of disease, the comparison group included 32 patients matched for age, sex and disease severity. Cerebrolysin promoted the early and complete reduction of common symptoms of brain injury as well as autonomic and asthenic disorders, restoration of cognitive functions, normalization of emotional condition, improvement of spontaneous bioelectrical activity. The drug was well-tolerated.